sur BIOMERIEUX (EPA:BIM)
BioMérieux Launches Salmonella Testing Kit on GENE-UP® TYPER
bioMérieux, a leader in in vitro diagnostics, has introduced the GENE-UP® TYPER SLM, a real-time PCR solution aimed at quickly identifying Salmonella in food industry settings. This innovation supports rapid root cause analysis, helping food manufacturers address potential contamination sources effectively. The GENE-UP® TYPER system, which combines molecular assays with a web application, offers rapid strain identification and aids in optimizing the manufacturing environment.
Salmonella enterica subspecies enterica, targeted by the new assay, is frequently associated with foodborne illnesses. By facilitating swift insights into contamination pathways, this tool aims to minimize foodborne disease outbreaks, safeguarding public health and reducing costly recalls for food companies.
This launch follows the 2025 introduction of GENE-UP® TYPER for Listeria monocytogenes and represents bioMérieux's ongoing effort to advance food safety through genomic technology and expert collaboration, particularly with Mérieux NutriSciences.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BIOMERIEUX